fbpx Skip to main content

Federal Policy Committee

Mission Statement

Biocom’s Federal Committee addresses legislative issues faced by the life science community of California and serves as a resource for all federal policy-related matters. The committee weighs in on legislative proposals affecting the industry, recommends official positions, shares insight on advocacy matters, and participates in policy events.

Committee Make-Up

The Committee is open to all Biocom members in good standing engaged or interested in federal policy. Regular participation in committee meetings or policy-related events is required to continue as a voting member of the committee.

Committee Overview

Committee members remain at the forefront of new federal developments through regular updates from Biocom staff on legislation, Congressional hearings, and administrative orders. Calls are held regularly in addition to in-person meetings hosted in Washington DC. Members located in California can join the meetings via teleconference.

Committee members oversee all of Biocom’s federal policy activities, including determining priorities, reviewing and discussing legislation, adopting positions on bills, strategizing on advocacy, and advising on communication and education initiatives.

In cases where more than one person within the same company participates in the committee, that company shall be limited to one vote on any voting issues. All adopted positions are sent to Biocom’s Board-level policy committee for final approval.

 

Biocom Staff Contact: Laure Fabrega, Director of Federal Policy and Government Affairs, lfabrega@biocom.org

Committee Chairs:

  • Nickie Currie, Amgen
  • Jessica Johnston, BD